MEETINGS - CE-marking a medical device - what does it really involve? (UK) March 2005:
This article was originally published in Clinica
Executive Summary
CE-marking a medical device - what does it really involve? is the subject of a one-day workshop being hosted by The Organisation for Professionals in Regulatory Affairs (TOPRA) at the Ramada Plaza, Regents Park, London, on March 2 2005. For further information and registration, contact: TOPRA, 7 Heron Quays, Marsh Wall, London E14 4JB. Tel: +44 (0)20 7538 9502; fax: +44 (0)20 7515 7836; email: [email protected] www.topra.org
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.